Transaction Report:
(Note: With the exception of the correction of typographical or spelling errors that could be a source of ambiguity, letters and reports are not edited. The original formatting of letters and referee reports may not be reflected in this compilation.) 1st Editorial Decision 20 September 2011
Thank you for submitting your manuscript to the EMBO Journal. Your study has now been seen by two referees and their comments are provided below.
As you can see below the referees appreciate the genetic approach used to show that the kinetic of CD4/CD8 expression is important for CD4/CD8 cell fate decision and find the study well done. Referee #1 basically supports publication here as is, while referee #2 has some questions that should be resolved before publication here. Given these evaluations, I would like to invite you to submit a suitably revised manuscript for our consideration that addresses the raised concerns.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely,
Editor
The EMBO Journal REFEREE REPORTS Referee #1
In previous studies Singer and colleagues have provided convincing evidence that the kinetic of CD4 and CD8 coreceptor gene expression is an important factor that determines CD4/CD8 cell fate decision. Based on these results, they proposed the "kinetic signaling model" of CD4/CD8-lineage choice. A drawback of the previous studies was that coreceptor genes were exogenously expressed as transgenes driven by various CD8 or other cis-regulatory elements. Therefore on could argue that the timing and kinetic of transgenic coreceptor expression is differentially regulated compared to the expression of the endogenous coreceptor genes.
In this study, Singer and colleagues performed an elegant genetic approach to overcome some of the limitation of the transgenic systems. Adoro et al generated mice with a knockin of the CD4 gene into the CD8a gene locus. This novel "4in8" mouse strain, in which CD4 is regulated by the endogenous CD8 cis-elements, was subsequently crossed with CD4null, b2m-/-mice and also with TCR tg mice. The authors addressed the question whether TCR/MHC class II signaling on DP thymocytes with a CD4 coreceptor, which is expressed with the kinetic of the CD8 genes, leads to the development of helper or cytotoxic T cells. A central aspect of the kinetic signaling model is that persistent TCR-mediated positive selection signaling leads to CD4 lineage differentiation, while disruption of TCR signaling (due to transient down-regulation of CD8) leads to CD8 lineage cells. Since CD4 is inserted into the CD8 locus, signaled DP cells transiently down-regulated CD4 expression (like CD8 expression in wt mice) and as a consequence have transiently disrupted TCR (via MHC class II)-mediated positive selection signaling. In agreement with the kinetic signaling model, the authors observed the appearance of MHC class II-restricted CD4+ T cells with cytotoxic T cell properties. This demonstrates that thymocytes expressing CD4 with the kinetic of CD8 develop into cytotoxic T cells, thus proofing that the kinetic of coreceptor expression is critical for CD4/CD8-lineage choice. The results also imply that the strength of signaling is not a critical determinant of helper versus cytotoxic T lineage development.
Technically, these complex genetics experiments are very well performed and the data are convincing. There is no need for additional experiments to support the conclusion of the study.
Specific remarks to the authors:
The expression kinetic of CD4 and CD8 differs during T cell development. This is a consequence of the activity of the regulatory elements present in the coreceptor loci. It is not clear why the authors introduced the terminology "coreceptor gene imprinting" (also in the title) to describe the difference of the activity of coreceptor cis-elements, since the term "gene imprinting" implies/suggests a different mechanistic basis (i.e. parental origin-dependent expression of a gene and epigenetic regulation).
Referee #2
In this manuscript, Adoro et al. report novel findings whereby a CD4 coreceptor protein, when encoded at the cd8 coreceptor gene locus (a knockin approach was used to introduce a cd4 cDNA in place of the cd8 gene), induces developing thymocytes to adopt the cytotoxic lineage fate and express the cytotoxic-lineage transcription factor Runx3, as well. This intriguing phenotype, which they refer to as 'coreceptor gene imprinting', is convincingly demonstrated to be the result of cd8-encoded CD4 causing thymocytes undergoing MHC class-II-specific positive selection to express Runx3 and to differentiate into CD4+ cytotoxic T cells. This is possibly linked to the dynamic regulation (initial down-regulation, prior to re-activation) of expression of the inserted cd4 cDNA by cd8-locus associated enhancer elements, and notably the so-called E8II enhancer. From their data, the authors argue that lineage fate of coreceptor-dependent thymocytes is mostly determined by the corresponding coreceptor gene loci rather that by the strength or specificity of TCR/coreceptor signalling. Overall, this is a well-conducted study and the experiments are generally well controlled. However, one question I am worrying about is whether the reported results truly sustain this novel 'coreceptor imprinting paradigm', as claimed by the authors. Specifically, gene expression is known to depend on intricate interactions between enhancer and cognate regulatory sequences including promoters and, sometimes, additional intergenic cis-regulatory elements. In this context, the targeted locus appears to be modified immediately upstream of the replaced cd8 exons (according to Figure S1 ; a precise description of the cd8 regulatory sequences that were maintained at the targeted locus -and proof that they still function normally -is lacking); and insertion of the cd4 cDNA has contributed to remove significant amounts of intergenic sequences from the cd8 locus. Therefore, the possibility that cd8-locus specific regulation of expression of the inserted cd4 cDNA differs from normal physiological controls cannot be formally eliminated. Apparently, the E8II-CD4 transgene contains E8II cd8a enhancer and cd8a promoter sequences, but transgenes' behaviour may significantly differ from endogenous loci in terms of the regulation of gene expression. The authors should at least address these concerns in their discussion.
1st Revision -authors' response 23 September 2011
Response to the Referees' comments:
In addition to supportive comments, this referee did not like our use of the terminology 'coreceptor gene imprinting' because he thought the term 'gene imprinting' implies a different mechanistic basis than that described in our study.
We thank Referee #1 for his very supportive comments and appreciate that he found the manuscript convincing. Despite much effort, we have been unable to come up with a better term than 'coreceptor gene imprinting' to describe the impact of coreceptor gene loci on thymocyte lineage fate. Importantly, we have defined precisely what we mean by 'coreceptor gene imprinting' throughout the manuscript, including the abstract, introduction, and discussion.
Referee #2:
In addition to supportive comments, this referee requested that we acknowledge and discuss: (1) the possibility that the knock-in strategy used to generate 4in8 mice resulted in removal of potential intronic regulatory elements between exons I and V of the Cd8 gene locus; and (2) the possibility that the E8II enhancer element behaved differently in the E8II-CD4 reporter transgene than it does in the endogenous Cd8 gene locus.
We thank Referee #2 for his very supportive comments and for commending the novelty of our study.
(1) We agree that we cannot exclude the possibility that unknown intronic regulatory sequences located between exons I-V of the Cd8a gene were removed in the re-engineered Cd8 gene locus. However, we would like to point out that we failed to find any evidence for the existence of such unknown intronic regulatory sequences, as expression of CD8 proteins encoded by intact Cd8 genes and expression of CD4 proteins encoded by re-engineered Cd8 genes were precisely parallel on developing thymocytes, throughout positive selection, on post-selection peripheral T cells, and in their response to gamma-c cytokines. Nevertheless, we do agree with the reviewer that this possibility should be raised in the manuscript, so we have revised the discussion section of the manuscript to say: "Notably, our knock-in strategy did not affect any of the known cis regulatory elements in the Cd8 gene locus which are all located upstream of exon I and remained intact in the engineered Cd8a CD4 locus, although it remained formally possible that we disrupted important but unknown intronic regulatory elements between exons I-V of the Cd8 gene locus. However, contrary to this possibility, CD4 proteins encoded by re-engineered Cd8a CD4 genes and CD8 proteins encoded by endogenous Cd8a + genes were identically expressed on cells in the thymus and periphery and responded identically to stimulatory cytokines."
